Liaoning Cotech Bio Gen Pharmaceutical is Biotechnology in China that focus on recombinant therapeutic proteins business. Founded in 2008. They cover business area such as manufacturer, biopharmaceutical product, somatic cell, vaccine, allergy, gene therapy, tissue, recombinant therapeutic protein.
2008
( 16 years old in 2024 )
Recombinant Therapeutic Proteins
-
Liaoning Province Economic and Technological Development Zone
Hong Cassia Road 106
Benxi, 117004
China
Private
manufacturerbiopharmaceutical productsomatic cellvaccineallergygene therapytissuerecombinant therapeutic protein
* We use standard office opening hours in near Liaoning Cotech Bio Gen Pharmaceutical's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Liaoning Cotech Bio Gen Pharmaceutical is Biotechnology business from China that founded in 2008 (16 years old in 2024), Liaoning Cotech Bio Gen Pharmaceutical business is focusing on Recombinant Therapeutic Proteins.
Liaoning Cotech Bio Gen Pharmaceutical headquarter office and corporate office address is located in Liaoning Province Economic and Technological Development Zone Hong Cassia Road 106 Benxi, 117004 China.
Liaoning Cotech Bio Gen Pharmaceutical was founded in China.
In 2024, Liaoning Cotech Bio Gen Pharmaceutical is currently focus on recombinant therapeutic proteins sector.
Above is snippet of Google Trends for "recombinant therapeutic proteins" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Liaoning Cotech Bio Gen Pharmaceutical, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
